Skip to Main Content

Paper Details

Compatibility of recombinant tissue plasminogen activator (rtPA) and aflibercept or ranibizumab coapplied for neovascular age-related macular degeneration with submacular haemorrhage.
Br J Ophthalmol
22
2015
Author NameAffiliation
Jost HillenkampUniversity of Kiel, University Medical Center Schleswig-Holstein
  • 1 - 1

Datasets

Release 1.2